AURO LABORATORIES
Back to Cashflow Statement
|
AURO LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹14 Cr | ₹18 Cr | ₹19 Cr | ₹-8.18 Cr | ₹9.79 Cr |
What is the latest Cash Flow from Financing Activities ratio of AURO LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹14 Cr |
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹19 Cr |
| Mar2023 | ₹-8.18 Cr |
| Mar2022 | ₹9.79 Cr |
How is Cash Flow from Financing Activities of AURO LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹14 Cr | -20.64 | |
| Mar2025 | ₹18 Cr | -7.37 | |
| Mar2024 | ₹19 Cr | Positive | |
| Mar2023 | ₹-8.18 Cr | Negative | |
| Mar2022 | ₹9.79 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AURO LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AURO LABORATORIES | ₹141.6 Cr | 0.6% | -3.5% | 17% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
AURO LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AURO LABORATORIES | 0.6% |
-3.5% |
17% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses